These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. HAMP gene mutation c.208T>C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis. Majore S, Binni F, Pennese A, De Santis A, Crisi A, Grammatico P. Hum Mutat; 2004 Apr; 23(4):400. PubMed ID: 15024747 [Abstract] [Full Text] [Related]
25. Iron overload due to mutations in ferroportin. De Domenico I, Ward DM, Musci G, Kaplan J. Haematologica; 2006 Jan; 91(1):92-5. PubMed ID: 16434376 [Abstract] [Full Text] [Related]
26. Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV-positive women. Masaisa F, Breman C, Gahutu JB, Mukiibi J, Delanghe J, Philippé J. Ann Hematol; 2012 Jun; 91(6):911-6. PubMed ID: 22249207 [Abstract] [Full Text] [Related]
27. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype. Détivaud L, Island ML, Jouanolle AM, Ropert M, Bardou-Jacquet E, Le Lan C, Mosser A, Leroyer P, Deugnier Y, David V, Brissot P, Loréal O. Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237 [Abstract] [Full Text] [Related]
28. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis. Majore S, Bonaccorsi di Patti MC, Valiante M, Polticelli F, Cortese A, Di Bartolomeo S, De Bernardo C, De Muro M, Faienza F, Radio FC, Grammatico P, Musci G. Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924 [Abstract] [Full Text] [Related]
29. The dual loss and gain of function of the FPN1 iron exporter results in the ferroportin disease phenotype. Uguen K, Le Tertre M, Tchernitchko D, Elbahnsi A, Maestri S, Gourlaouen I, Férec C, Ka C, Callebaut I, Le Gac G. HGG Adv; 2024 Oct 10; 5(4):100335. PubMed ID: 39039793 [Abstract] [Full Text] [Related]
32. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC. Cell Metab; 2005 Mar 10; 1(3):191-200. PubMed ID: 16054062 [Abstract] [Full Text] [Related]
33. The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes. Ge XH, Wang Q, Qian ZM, Zhu L, Du F, Yung WH, Yang L, Ke Y. J Nutr Biochem; 2009 Nov 10; 20(11):860-5. PubMed ID: 19027283 [Abstract] [Full Text] [Related]
34. Iron overload in the Asian community. Lok CY, Merryweather-Clarke AT, Viprakasit V, Chinthammitr Y, Srichairatanakool S, Limwongse C, Oleesky D, Robins AJ, Hudson J, Wai P, Premawardhena A, de Silva HJ, Dassanayake A, McKeown C, Jackson M, Gama R, Khan N, Newman W, Banait G, Chilton A, Wilson-Morkeh I, Weatherall DJ, Robson KJ. Blood; 2009 Jul 02; 114(1):20-5. PubMed ID: 19342478 [Abstract] [Full Text] [Related]
35. Effect of ferroportin polymorphism on iron homeostasis and infection. Kasvosve I. Clin Chim Acta; 2013 Feb 01; 416():20-5. PubMed ID: 23178444 [Abstract] [Full Text] [Related]